Journal
CANCER
Volume 117, Issue 14, Pages 3112-3117Publisher
WILEY-BLACKWELL
DOI: 10.1002/cncr.25876
Keywords
CDH1; E-cadherin; germline; lobular breast cancer; diffuse gastric cancer; inherited
Categories
Funding
- FEDER (Fonds Europeens de Developpement en Region) [31,355-2008]
- Clermont Communaute
Ask authors/readers for more resources
Present data are highly suggestive but do not unequivocally prove the cosegregation of germ-line CDH1 mutations with inherited invasive lobular breast cancer (ILBC). METHODS: Two Caucasian families with 6 pathologically confirmed ILBC cases but no diffuse gastric cancer (DGC) were identified in our oncogenetics consultations. Screening for mutations of CDH1, BRCA1, and BRCA2 genes was performed on blood samples. When available, loss of heterozygosity (LOH) and immunohistochemistry (IHC) analyses were performed on tumor samples. RESULTS: No BRCA1 or BRCA2 mutation was found. Deleterious CDH1 germ-line mutations c.283C>T and c.1582del were found in all the 4 living women with ILBC in family 1 and family 2, respectively. The mutation c.283C>T was also present in a healthy 71-year-old male and 2 obligate carriers in family 1. No DGC was observed in the 2 families. Loss of the wildtype CDH1 allele in 1 of the breast tumors was confirmed by LOH and IHC studies, in accordance with the 2-hit model of tumor suppressor genes. CONCLUSIONS: Germ line CDH1 mutation can be cosegregated with ILBC in the absence of DGC. Present data do not support recommendation of prophylactic gastrectomy in CDH1 germline mutation carriers with ILBC. Cancer 2011;117:3112-7. (C) 2077 American Cancer Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available